Financial Survey: COLLPLANT HOLDI/S (CLGN) vs. Bionik Laboratories (BNKL)
COLLPLANT HOLDI/S (NASDAQ:CLGN) and Bionik Laboratories (OTCMKTS:BNKL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.
Earnings & Valuation
This table compares COLLPLANT HOLDI/S and Bionik Laboratories’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|COLLPLANT HOLDI/S||$480,000.00||35.63||-$6.02 million||($2.26)||-2.21|
|Bionik Laboratories||$990,000.00||12.46||-$14.62 million||N/A||N/A|
This table compares COLLPLANT HOLDI/S and Bionik Laboratories’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current recommendations for COLLPLANT HOLDI/S and Bionik Laboratories, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
COLLPLANT HOLDI/S currently has a consensus target price of $7.00, indicating a potential upside of 40.00%. Given COLLPLANT HOLDI/S’s higher possible upside, research analysts plainly believe COLLPLANT HOLDI/S is more favorable than Bionik Laboratories.
Institutional and Insider Ownership
0.8% of COLLPLANT HOLDI/S shares are held by institutional investors. 45.0% of Bionik Laboratories shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
COLLPLANT HOLDI/S beats Bionik Laboratories on 7 of the 10 factors compared between the two stocks.
About COLLPLANT HOLDI/S
CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix intended for treatment of tendinopathy; Vergenix FG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. has a license, development, and commercialization agreement with United Therapeutics Corporation for 3D bioprinting of solid-organ scaffolds for human transplants. The company is headquartered in Ness Ziona, Israel.
About Bionik Laboratories
Bionik Laboratories Corp., a robotics company, focuses on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. The company specializes in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Systems, which include the InMotion ARM that allows clinicians to deliver sensor motor therapy to the shoulder and elbow to develop new neural pathways; InMotion ARM/HAND, an add-on module to be used with the InMotion ARM; and InMotion WRIST, a rehabilitation device that enables clinicians to deliver optimum intensive sensor motor wrist and forearm therapy to patients with neurological conditions. The company is also developing InMotion HOME, an upper extremity product that allows patients to extend their therapy for as long as needed while rehabilitating at home; and ARKE, a robotic lower body exoskeleton designed for wheelchair bound individuals suffering from spinal cord injuries, stroke, and other mobility disabilities. Bionik Laboratories Corp. was founded in 2010 and is headquartered in Toronto, Canada.
Receive News & Ratings for COLLPLANT HOLDI/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLLPLANT HOLDI/S and related companies with MarketBeat.com's FREE daily email newsletter.